Immunic
IMUX
$1.24
Share price
-0.40%
Change (1 day)
-31.22%
Change (1 year)
Categories
Immunic (IMUX) - P/B ratio
P/B ratio as of May 2024 : 3.89
According to Immunic's latest financial reports the company has a price-to-book ratio of 3.89.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Immunic - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.34 | 328.49% |
| 2022-12-31 | 0.5463 | -72.36% |
| 2021-12-31 | 1.98 | -3.05% |
| 2020-12-31 | 2.04 | 14.14% |
| 2019-12-31 | 1.79 | 181.15% |
| 2018-12-31 | 0.6352 | -87.34% |
| 2017-12-31 | 5.02 | 110.37% |
| 2016-12-31 | 2.39 | -44.06% |
| 2015-12-31 | 4.26 | -30.42% |
| 2014-12-31 | 6.13 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -30.27% | 🇺🇸 USA |